1960 related articles for article (PubMed ID: 32612154)
21. Insights Gained from Single-Cell Analysis of Immune Cells in the Tumor Microenvironment.
Ren X; Zhang L; Zhang Y; Li Z; Siemers N; Zhang Z
Annu Rev Immunol; 2021 Apr; 39():583-609. PubMed ID: 33637019
[TBL] [Abstract][Full Text] [Related]
22. Characteristics of Tumor-Infiltrating Lymphocytes Prior to and During Immune Checkpoint Inhibitor Therapy.
Plesca I; Tunger A; Müller L; Wehner R; Lai X; Grimm MO; Rutella S; Bachmann M; Schmitz M
Front Immunol; 2020; 11():364. PubMed ID: 32194568
[TBL] [Abstract][Full Text] [Related]
23. Single-cell transcriptome analysis reveals TOX as a promoting factor for T cell exhaustion and a predictor for anti-PD-1 responses in human cancer.
Kim K; Park S; Park SY; Kim G; Park SM; Cho JW; Kim DH; Park YM; Koh YW; Kim HR; Ha SJ; Lee I
Genome Med; 2020 Feb; 12(1):22. PubMed ID: 32111241
[TBL] [Abstract][Full Text] [Related]
24. T-cell adoptive immunotherapy using tumor-infiltrating T cells and genetically engineered TCR-T cells.
Ikeda H
Int Immunol; 2016 Jul; 28(7):349-53. PubMed ID: 27127191
[TBL] [Abstract][Full Text] [Related]
25. Checkpoint blockade-based immunotherapy in the context of tumor microenvironment: Opportunities and challenges.
Duan J; Wang Y; Jiao S
Cancer Med; 2018 Sep; 7(9):4517-4529. PubMed ID: 30088347
[TBL] [Abstract][Full Text] [Related]
26. Immune checkpoint inhibitors in cancer therapy: a focus on T-regulatory cells.
Sasidharan Nair V; Elkord E
Immunol Cell Biol; 2018 Jan; 96(1):21-33. PubMed ID: 29359507
[TBL] [Abstract][Full Text] [Related]
27. Editorial: CD4
González-Navajas JM; Elkord E; Lee J
Front Immunol; 2021; 12():737615. PubMed ID: 34552596
[No Abstract] [Full Text] [Related]
28. The current landscape of single-cell transcriptomics for cancer immunotherapy.
Guruprasad P; Lee YG; Kim KH; Ruella M
J Exp Med; 2021 Jan; 218(1):. PubMed ID: 33601414
[TBL] [Abstract][Full Text] [Related]
29. Combining Oncolytic Viruses With Cancer Immunotherapy: Establishing a New Generation of Cancer Treatment.
Shi T; Song X; Wang Y; Liu F; Wei J
Front Immunol; 2020; 11():683. PubMed ID: 32411132
[TBL] [Abstract][Full Text] [Related]
30. Talkin' Toxins: From Coley's to Modern Cancer Immunotherapy.
Carlson RD; Flickinger JC; Snook AE
Toxins (Basel); 2020 Apr; 12(4):. PubMed ID: 32283684
[TBL] [Abstract][Full Text] [Related]
31. Cancer Immunotherapies: From Efficacy to Resistance Mechanisms - Not Only Checkpoint Matters.
Wang S; Xie K; Liu T
Front Immunol; 2021; 12():690112. PubMed ID: 34367148
[TBL] [Abstract][Full Text] [Related]
32. Immunotherapy and tumor microenvironment.
Tang H; Qiao J; Fu YX
Cancer Lett; 2016 Jan; 370(1):85-90. PubMed ID: 26477683
[TBL] [Abstract][Full Text] [Related]
33. Immune contexture defined by single cell technology for prognosis prediction and immunotherapy guidance in cancer.
Wu T; Wu X; Wang HY; Chen L
Cancer Commun (Lond); 2019 Apr; 39(1):21. PubMed ID: 30999966
[TBL] [Abstract][Full Text] [Related]
34. Single-Cell Omics in Dissecting Immune Microenvironment of Malignant Gliomas-Challenges and Perspectives.
Kaminska B; Ochocka N; Segit P
Cells; 2021 Aug; 10(9):. PubMed ID: 34571910
[TBL] [Abstract][Full Text] [Related]
35. Role of tumor-infiltrating lymphocytes in patients with solid tumors: Can a drop dig a stone?
Badalamenti G; Fanale D; Incorvaia L; Barraco N; Listì A; Maragliano R; Vincenzi B; Calò V; Iovanna JL; Bazan V; Russo A
Cell Immunol; 2019 Sep; 343():103753. PubMed ID: 29395859
[TBL] [Abstract][Full Text] [Related]
36. Recharacterizing Tumor-Infiltrating Lymphocytes by Single-Cell RNA Sequencing.
Zhang L; Zhang Z
Cancer Immunol Res; 2019 Jul; 7(7):1040-1046. PubMed ID: 31262773
[TBL] [Abstract][Full Text] [Related]
37. Targeting tumor-associated macrophages to synergize tumor immunotherapy.
Xiang X; Wang J; Lu D; Xu X
Signal Transduct Target Ther; 2021 Feb; 6(1):75. PubMed ID: 33619259
[TBL] [Abstract][Full Text] [Related]
38. Inhibition of vascular adhesion protein-1 enhances the anti-tumor effects of immune checkpoint inhibitors.
Kinoshita T; Sayem MA; Yaguchi T; Kharma B; Morii K; Kato D; Ohta S; Mashima Y; Asamura H; Kawakami Y
Cancer Sci; 2021 Apr; 112(4):1390-1401. PubMed ID: 33453147
[TBL] [Abstract][Full Text] [Related]
39. Understanding tumor-infiltrating lymphocytes by single cell RNA sequencing.
Ren X; Zhang Z
Adv Immunol; 2019; 144():217-245. PubMed ID: 31699218
[TBL] [Abstract][Full Text] [Related]
40. Hijacked Immune Cells in the Tumor Microenvironment: Molecular Mechanisms of Immunosuppression and Cues to Improve T Cell-Based Immunotherapy of Solid Tumors.
Balta E; Wabnitz GH; Samstag Y
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34072260
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
